Related Experiment Video
Updated: Feb 27, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Feline Cardiogenic Arterial Thromboembolism: Prevention and Therapy
1Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, Lynn Hall, 625 Harrison Street, West Lafayette, IN 47907-2026, USA.
Insights
Feline cardiogenic arterial thromboembolism (CATE) is a severe condition in cats. Clopidogrel is more effective than aspirin for preventing CATE recurrence, offering a better long-term outcome.
Area of Science:
- Veterinary Cardiology
- Thrombotic Disease Research
- Feline Medicine
Background:
- Feline cardiogenic arterial thromboembolism (CATE) is a critical condition with high mortality.
- A significant portion of CATE mortality results from euthanasia.
- Current management involves inducing a hypocoagulable state and supportive care.
Purpose of the Study:
- To evaluate management strategies for feline cardiogenic arterial thromboembolism.
- To compare the efficacy of different preventive protocols for CATE.
- To assess the long-term outcomes of CATE management in cats.
Main Methods:
- Review of short-term management focusing on hypocoagulability and blood flow.
- Analysis of preventive protocols, including antiplatelet and anticoagulant drugs.
- Examination of data from the only prospective clinical trial comparing clopidogrel and aspirin.
Main Results:
- Clopidogrel demonstrated superiority over aspirin in a prospective clinical trial.
- Clopidogrel was associated with a lower CATE recurrence rate.
- Cats treated with clopidogrel experienced a longer time to recurrent CATE.
Conclusions:
- Clopidogrel is a superior preventive treatment for feline cardiogenic arterial thromboembolism compared to aspirin.
- Optimal management includes a 72-hour treatment window to determine the acute clinical course.
- Emerging anticoagulant drugs show potential for future CATE management.
Abstract:
Feline cardiogenic arterial thromboembolism (CATE) is a devastating disease whereby 33% of cats survive their initial event, although approximately 50% of mortality is from euthanasia. Short-term management focuses on inducing a hypocoagulable state, improving blood flow, and providing supportive care. Ideally, all cats should be given 72 hours of treatment to determine the acute clinical course. Preventive protocols include antiplatelet and/or anticoagulant drugs, with the only prospective clinical trial demonstrating that clopidogrel is superior to aspirin with a lower CATE recurrence rate and longer time to recurrent CATE. Newer anticoagulant drugs hold great promise in the future of managing this disease.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Atherosclerosis III: Management
Myocarditis III: Medical Management

